Trial intelligence / Profile preview

Xuefu Zhuyu oral liquid for primary dysmenorrhea

ChiCTR1900026819Phase 4Recruiting

Sponsor
First Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Start
Nov 2019
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of xuefu zhuyu in primary dysmenorrhea (PD) (2 arms), sponsored by First Affiliated Hospital of Liaoning University of Traditional Chinese Medicine. Primary endpoint: Change of mean pain intensity. Started Nov 2019; status: recruiting.

02

Drugs

xuefu zhuyu
03

Conditions

primary dysmenorrhea (PD)

Beyond the preview

Go deeper on ChiCTR1900026819.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1900026819.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call